no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy
|
Pishvaian, Michael J. |
|
2012 |
70 |
6 |
p. 843-853 |
article |
2 |
A phase I trial of nab-paclitaxel, gemcitabine, and capecitabine for metastatic pancreatic cancer
|
Ko, Andrew H. |
|
2012 |
70 |
6 |
p. 875-881 |
article |
3 |
Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro
|
Huang, Chongmei |
|
2012 |
70 |
6 |
p. 801-809 |
article |
4 |
Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas
|
Bernstein-Molho, Rinat |
|
2012 |
70 |
6 |
p. 855-860 |
article |
5 |
Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies
|
Zhang, Da |
|
2012 |
70 |
6 |
p. 891-898 |
article |
6 |
Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials
|
Qiu, Man-Tang |
|
2012 |
70 |
6 |
p. 861-873 |
article |
7 |
6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation
|
El-Bakly, Wesam M. |
|
2012 |
70 |
6 |
p. 833-841 |
article |
8 |
High-dose etoposide in allogeneic stem cell transplantation
|
Bruserud, Øystein |
|
2012 |
70 |
6 |
p. 765-782 |
article |
9 |
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer
|
Lucchetta, Marta |
|
2012 |
70 |
6 |
p. 899-902 |
article |
10 |
Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment
|
Devriese, L. A. |
|
2012 |
70 |
6 |
p. 823-832 |
article |
11 |
Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer
|
Shiroyama, Takayuki |
|
2012 |
70 |
6 |
p. 783-789 |
article |
12 |
Phase I study of nelfinavir in liposarcoma
|
Pan, Janet |
|
2012 |
70 |
6 |
p. 791-799 |
article |
13 |
Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models
|
Meco, Daniela |
|
2012 |
70 |
6 |
p. 811-822 |
article |
14 |
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer
|
Provencio, M. |
|
2012 |
70 |
6 |
p. 883-890 |
article |